Full Press Release Details
NOTICE OF ANNUAL GENERAL MEETING
24 MAY 2023 AT 14:00 (CEST)
The board of directors hereby convenes the Annual
General Meeting of Evaxion Biotech A/S, company registration (CVR) no. 31 76 28 63 (the "Company"), to be held on
24 May 2023 AT 14:00 (CEST)
at Evaxion Biotech A/S, Dr Neergaards Vej 5F, 2970
The board of directors
proposes that attorney-at-law Lars L thjohan be elected as chairman of the general meeting.
Chairperson Marianne
S gaard will report on the Company's activities for the year ended December 31, 2022.
The board of directors
recommends that the Company's audited annual report for the financial year 2022 be approved. The audited annual report is available on
the Company's website.
The board of directors
proposes that the loss be carried forward to the next financial year.
The board of directors
currently consists of the following members: Marianne S gaard (chair-person), Steven J. Projan, Lars Holtug, Roberto Prego and
Niels Iversen M ller.
The board of directors
proposes the re-election of Marianne S gaard, Lars Holtug, Roberto Prego and Niels Iversen M ller.
resigns from the board of directors at the Annual General Meeting and does not seek re-election.
A description of the
proposed candidates' qualifications, hereunder information about similar positions possessed by the candidates at the time of the
Annual General Meeting can be found in appendix 1 attached hereto.
The board of directors
proposes that EY Godkendt Revisionspartnerselskab, CVR no. 30700228, be re-elected as the auditor of the Company.
No motions received.
The Board of Directors
proposes to authorize the chairman of the meeting (with a right of substitution) on behalf of the Company to apply the Danish Business
Authority for registration of the resolutions passed by the General Meeting and in this connection to make any such amendments to the
documents prepared for such resolutions that may be required for registration with the Danish Business Authority.
H rsholm, Denmark, 4 May 2023
The board of directors of Evaxion Biotech
Chairperson of the board of directors
Adoption requirements
All proposals on the agenda may be adopted by a simple
majority of the votes cast.
Share capital and voting rights
The Company's nominal share capital
currently amounts to DKK 26,438,007 divided into 26,438,007 shares of DKK 1.00 nominal value. At the Annual General Meeting, each share
The right of a shareholder
to attend the Annual General Meeting and to vote in respect of his/her shares is determined on the basis of the shares held by the shareholder
at the record date. The shareholdings and voting rights are calculated on the basis of entries in the register of shareholders and any
notice of ownership received by the Company for the purpose of registration in the register of shareholders.
The record date is 17 May 2023.
Furthermore, participation
is conditional upon the shareholder having timely notified the Company of his/her attendance as described below.
Attendance and admission
Shareholders, proxies and any accompanying
advisor wishing to attend the Annual General Meeting in person must have an admission card. Admission cards may be ordered on the website
of Computershare: www.computershare.com.
Admission cards must be ordered no later than 19 May
2023 at 23:59 (CEST).
Shareholders can vote by proxy no later than 19 May
2023 at 23:59 (CEST).
The proxy can be submitted in writing by using
the proxy form which is attached to the convening notice and can be downloaded from the Company's website: www.evaxion-biotech.com.
If the form is used, it must be completed, signed and forwarded to Computershare A/S, Lottenborgsvej 26 D, 1st floor, DK-2800 Kgs. Lyngby,
Denmark, by mail. Computershare must receive completed proxy forms no later than 19 May 2023 at 23:59 (CEST).
Proxies may also be granted electronically on
the website of Computershare, www.computershare.dk, by using a Computershare username and password. Usernames and passwords will
be sent to all shareholders by email. Electronic proxies must be granted no later than 19 May 2023 at 23:59 (CEST).
Votes by correspondence
Shareholders can vote by correspondence no later than
23 May 2023 at 11:59 (CEST).
The vote by correspondence can be submitted
in writing by using the correspondence form which is attached to convening notice and can be downloaded from the Company's website:
www.evaxion-biotech.com. If the form is used, it must be completed, signed and forwarded to Computershare A/S, Lottenborgsvej
26 D, 1st floor, DK-2800 Kgs. Lyngby, Denmark, by mail.
It is also possible to vote electronically on the website
of Computershare, www.computershare.dk, by using a Computershare username and password.
Additional information
On the Company's website, www.evaxion-biotech.com,
the following information is available:
The convening notice will also be forwarded
in writing to all shareholders recorded in the register of shareholders who have requested such notification.
The Annual General Meeting will be conducted
in English according to section 4.8 of the Company's Articles of Association.